Menu
Currency
GWAS Study

Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.

Sherva R, Gross A, Mukherjee S et al.

32573913 PubMed ID
GWAS Study Type
3946 Participants
82 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SR
Sherva R
GA
Gross A
MS
Mukherjee S
KR
Koesterer R
AP
Amouyel P
BC
Bellenguez C
DC
Dufouil C
BD
Bennett DA
CL
Chibnik L
CC
Cruchaga C
DJ
Del-Aguila J
FL
Farrer LA
MR
Mayeux R
ML
Munsie L
WA
Winslow A
NS
Newhouse S
SA
Saykin AJ
KJ
Kauwe JSK
CP
Crane PK
GR
Green RC
Chapter II

Abstract

Summary of the research findings

Introduction: Variability exists in the disease trajectories of Alzheimer's disease (AD) patients. We performed a genome-wide association study to examine rate of cognitive decline (ROD) in patients with AD.

3,946 European ancestry cases

Chapter III

Study Statistics

Key metrics and study information

3946
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.